Announcements 2024
Update on Strategic Partnership in North America – 16/12/2024
Receipt of initial upfront US$300,000 Royalty Payment – 21/10/2024
Further Update on Strategic Licensing and Partnership Agreement for North America – 03/10/2024
Interim results for the six months ended 30 June 2024 – 30/09/2024
Holdings in Company – 16/09/2024
Collaboration with Moffitt Cancer Center to evaluate patients with suspected lung cancer – 09/09/2024
Update on Strategic Licensing Partnership in North America – 25/07/2024
Manufacturing Agreement with BBI Solutions – 18/07/2024
Result of AGM – 24/06/2024
Update on North American Strategic Licensing MoU – 17/06/2024
Notice of Annual General Meeting – 03/06/2024
Holdings in Company – 13/05/2024
Total Voting Rights – 30/04/2024
Final results for the year ended 31 December 2023 – 30/04/2024
Holdings in Company – 23/04/2024
Strategic Licensing and Partnership Memorandum of Understanding for North America – 02/04/2024
Placing to raise £0.62 million and Appointment of Joint Broker – 26/03/2024
